A new dawn: Managing IP’s China Special Focus 2023 launched

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

A new dawn: Managing IP’s China Special Focus 2023 launched

terrace-4440132.jpg

As China wakes up to a raft of new laws and innovations, Managing IP partnered with the country’s leading IP experts to meet the sunrise

With the 2021 amendment to China’s Patent Law in full force, and with rights holders adopting increasingly aggressive damages claims in China’s courts, there is much for businesses and IP professionals to keep abreast of.

As such, authors from Chang Tsi & Partners analyse the new Patent Law, as the country strives for a competitive IP protection platform on the global stage. Chinese courts are playing an active role in shaping global IP governance rules by issuing anti-suit injunctions and asserting their jurisdiction over SEP's global rate, further cementing China's position as a preferred destination for international IP litigation.

In light of this dynamic IP litigation landscape, experts from Wanhuida outline the various defence mechanisms patentees have at their disposal when facing infringement accusations in China.

And in a similar vein, authors from CCPIT Patent and Trademark Law Office use practical knowledge to illustrate the evidence rights holders need to effectively protect their IP and win significant damages in China.

Likewise, Liu, Shen & Associates' article weighs up the pros and cons of pursuing both civil litigation and administrative action when seeking IP protection in China.

HFG Law & Intellectual Property's experts analyse how the applicability of trademarks has evolved amid the widespread use of original equipment manufacturers in China by overseas companies.

Meanwhile, DEQI Intellectual Property’s article clarifies some of the complexities surrounding divisional application strategies in China.

In addition, authors from AFD China Intellectual Property Law Office review China’s recent high-level decisions on trademark ‘use’, with valuable lessons for infringement.

Finally, Kangxin Partners's article considers what patentees can do to prevent claims being declared invalid because their amendments go beyond the scope of the original application.

We hope you enjoy reading our expert commentary on all the important issues shaping China’s IP environment in 2023.

Click here to read all the chapters from Managing IP's China Special Focus 2023.

more from across site and SHARED ros bottom lb

More from across our site

Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Gift this article